11 – 20 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Care pathways in atopic dermatitis : a retrospective population-based cohort study
(
- Contribution to journal › Article
-
Mark
Impact on quality of life of an intervention providing additional information to patients with allergic contact dermatitis; a randomized clinical trial
(
- Contribution to journal › Article
- 2021
-
Mark
Methods to improve quality of life, beyond medicines. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes
(
- Contribution to journal › Article
-
Mark
Selection process of measures for core outcome set should utilize the highest methodology level and should be maximally free of bias. Comment on ‘IDQoL, CDLQI and the 45-item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan : a group discussion study’
(
- Contribution to journal › Letter
-
Mark
Dermatology textbooks in Scandinavia should prepare medical students for ethnic diversity
(
- Contribution to journal › Letter
-
Mark
Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project)
(
- Contribution to journal › Article
-
Mark
A position paper on the management of itch and pain in atopic dermatitis from the International Society of Atopic Dermatitis (ISAD)/Oriented Patient-Education Network in Dermatology (OPENED) task force
(
- Contribution to journal › Article
-
Mark
Validation of questionnaire algorithm based on repeated open application testing with the constituents of fragrance mix II : the EDEN Fragrance Study
(
- Contribution to journal › Article
-
Mark
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
(
- Contribution to journal › Letter
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
(
- Contribution to journal › Letter